| Date |
Title |
| 1/9/2012 |
Stemline Therapeutics, Inc. Names Eric K. Rowinsky, M.D. Chief Medical Officer and Head of Research and Development |
|
| 12/12/2011 |
Stemline Therapeutics, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference |
|
| 12/8/2011 |
Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH) |
|
| 6/2/2011 |
Stemline Therapeutics, Inc. Announces Oral Presentation of Positive Phase I/II Trial Results with Novel Brain Cancer Vaccine at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting |
|
| 3/9/2011 |
Stemline Therapeutics Receives Orphan Drug Designation for SL-401 for the Treatment of Acute Myeloid Leukemia |
|
| 2/23/2011 |
Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh |
|
| 12/1/2010 |
Stemline Therapeutics, Inc. Announces Presentations of SL-401 Clinical and Pre-Clinical Efficacy at the 52nd Annual Meeting of the American Society of Hematology (ASH) |
|
| 10/26/2010 |
Stemline CEO to Chair clinical trial session of World Cancer Stem Cell Conference (Dec. 9, 2010) |
|
| 7/20/2010 |
CEO of Stemline invited to present at Drug Discovery and Development Conference (Aug. 4, 2010) |
|
| 3/21/2010 |
Stemline CEO invited to speak at Cancer Stem Cell conference (Mar. 24-25, 2010) |
|
| 12/4/2009 |
Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) |
|
| 11/30/2009 |
Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of MD Anderson Cancer Center |
|
| 7/30/2009 |
Stemline CEO is invited speaker at New Frontiers in Cancer Drug Development (Aug. 4-6, 2009) |
|
| 2/5/2009 |
Nature BioCentury (SciBx) interviews Stemline’s Director of Operations in Notch signaling article |
|
| 4/9/2008 |
Stemline Therapeutics raises $12.5 million |
|
| 12/10/2007 |
L.A. Times cites Stemline and CEO |
|
| 5/10/2007 |
Stemline and CEO cited in Oncology Times article |
|
| 5/7/2007 |
Stemline CEO is a panelist and speaker at BIO 2007 |
|
| 3/7/2007 |
Stemline Therapeutics In-Licenses Phase I Oncology Compound |
|
| 12/7/2006 |
Stemline CEO is an invited speaker at the New York Academy of Sciences |
|
| 9/29/2006 |
Stemline is awarded a National Institutes of Health STTR grant |
|
| 1/20/2005 |
Stemline is cited in New Scientist article |
|
| 1/18/2005 |
Stemline is cited in BBC article |
|
| 1/17/2005 |
Stemline licenses high throughput drug discovery technology from University of Cambridge |
|
